**Abstract**

**Objective:** Early antidepressant response predicts later treatment outcome in patients with major depressive disorder (MDD) \[1\]. MDD is characterized by changes to the behavioral and neuronal correlates of emotion processing \[2\]. Functional magnetic resonance imaging (fMRI) studies have demonstrated that neuronal activity related to emotion processing allows for prediction of antidepressant response after 6--8 weeks \[3, 4\]. We aimed to investigate if emotion processing related fMRI activity predicts early response to antidepressant psychopharmacologic treatment.

**Methods:** 23 MDD patients (16 female, mean age±SD=32.61±9.44 years) were investigated once with fMRI (EPI-sequence, TE/TR=23/1400ms, matrix size 128x128 voxel, FOV 192x192 mm, 78 slices of 1mm with 0.25 mm gap, Siemens Magnetom 7T scanner), during which they performed a block-design emotion discrimination task (EDT). Standard preprocessing was carried out using SPM12. First level analysis comprised the contrast EDT vs. the control condition (object discrimination task, ODT). Following baseline fMRI, patients received Escitalopram in a flexible dose schema and were assessed with the Hamilton Depression Rating Scale (HAM-D) after 2 and 4 weeks of treatment. Correlation analyses were performed using SPM12.

**Results:** Deactivation of the posterior cingulate cortex at baseline correlated with change in HAM-D scores from baseline to 2-weeks after treatment start (p \< 0.05 cluster level FWE-corrected). This correlation remained significant when correcting for baseline symptom severity, age, and sex (p \< 0.05 cluster level FWE-corrected). Baseline EDT vs. ODT activity did not correlate with HAM-D change after four weeks of Escitalopram treatment.

**Conclusion:** As an emotion-processing task, the EDT represents a promising target for fMRI response prediction studies, considering the integral nature of affective and emotional dysregulation to MDD. The lack of correlation between baseline fMRI activity and HAM-D reduction by 4 weeks suggests that neuronal processes related to early response may differ from those associated with more long-term outcome.
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